Site records / India / FEI 3004497364
Centrient Pharmaceuticals India Private LimitedNawanshahr
FDA-registered drug establishment in Nawanshahr: api manufacture. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.
- Inspections posted
- 4
- Last inspection
- Jan 2026 · OAI
- Warning letters to this FEI
- 1
- Import alerts at this address
- 1
- US border refusals, 2 years
- 0
This site, graded.
Every fact sourced.
- A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
- Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
- Warning-letter violations, numbered and labelled
- Import-alert history rebuilt from the archive, each listing checked against this address
- Border refusals by product, and the company's other sites, each graded
- A hash of every source read, so the PDF can be checked against the record
On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.
PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.
By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.
Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan
Inspections
4 FDA inspections of this FEI, by end date; 4 with a posted classification.
- 27 Jan 2026OAI · Official Action IndicatedDrug Quality Assurance · no citations posted
- 1 Jul 2022OAI · Official Action IndicatedDrug Quality Assurance · no citations posted
- 20 Apr 2018OAI · Official Action IndicatedDrug Quality Assurance · no citations posted
- 18 Dec 2015VAI · Voluntary Action IndicatedDrug Quality Assurance · no citations posted
Warning letters and compliance actions
- 7 Dec 2022Warning Letter · CDER SourceCGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Import alerts in force
Import-alert pages list a firm name and an address, never an FEI. Each listing under this firm's name is shown with the address FDA published and whether it is this site's.
- 21 Nov 2022Import alert 66-40 · Published address is this site SourcePublished address: Bhai Mohan Singh Nagar , Village Toansa, District Sbs Nagar , Nawashahr, Punjab INDIA
Registration
- FEI
- 3004497364
- DUNS
- 860184986
- Registered as
- CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED
- Registrant
- Centrient Pharmaceuticals Netherlands B.V.
- Address
- Bhai Mohan Singh Nagar,Toansa, District SBS Nagar, Nawanshahr, PB 144533, India (IND)
- Operations
- API MANUFACTURE
- Registration expires
- 31 Dec 2026
Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.